Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Jurgis Bekepuris who wrote (41540)	2/28/2011 10:39:32 PM
From: Grantcw	Respond to of 78596

Hello Jurgis, Yes, I'm interested in biotechs these days, hence the GILD question. The p/e looks good compared to potential growth. I'm still trying to figure out this revenue multiplier valuation and how that works in. Supposedly, 2.5x revenue is a normal valuation of a biotech, though 1-5x is supposedly reasonable? GILD at 4x may be a little high for me on that end, but I'll admit to still learning. I definitely like the p/e. I may buy some shares after watching for a while. Have a great time in Tanzania! My wife and I were trying to get to Africa for our 10-year anniversary this year, but we ended up in Istanbul instead. And we thought we were adventurous. :) Thanks, Grant